DCRI faculty member recognized by American Gastroenterological Association

March 4, 2019 – The DCRI’s David Leiman, MD, MSHP was selected as one of 18 participants in this year’s AGA Future Leaders Program.

DCRI gastroenterologist David Leiman, MD, MSHP will be a member of the third class of the Future Leaders Program,  the flagship leadership development program offered by the American Gastroenterological Association (AGA).

The 18-month Future Leaders Program was designed for early career physicians and scientists who have the potential to make a significant impact in their specialty area. The program seeks to shape its participants into the future leaders of the AGA, their home institutions, and within the field of digestive diseases.

“The 2020 class of AGA Future Leaders represents the next generation of leaders in our field,” said Darrell S. Pardi, MD, MSc, AGAF, co-program chair for the AGA Future Leaders Program. “Along with my co-chair, Sheryl Pfeil, MD, AGAF, and the esteemed mentors and faculty participating in this program, we look forward to cultivating these rising stars who stand out for their current achievements, commitment to advancing the field, and potential for future success.”

Leiman’s research focuses on esophageal diseases, swallowing disorders, and gastrointestinal cancer prevention. He is particularly interested in health care delivery, with a focus on clinical effectiveness, practice quality and patient outcomes. He is already involved in the AGA through membership on its Quality Measures Committee and was recently selected as Chair-Elect.

“I am honored to be selected as a participant of the Future Leaders Program and to join an exciting group of talented colleagues from across the country,” Leiman said. “I am looking forward to learning new leadership strategies that can be applied across my research and clinical practice as well as building long-lasting relationships with my peers and future mentors.”

In the Future Leader Program, Leiman joins colleagues from Columbia University, Harvard University, the University of Pennsylvania, and the University of North Carolina at Chapel Hill, among other institutions.

“David has been an outstanding recruit to Duke GI and the DCRI,” said Andrew J. Muir, MD, MHS, director of gastroenterology and hepatology research at the DCRI. “This selection by the AGA recognizes David’s accomplishments in this early phase of his career.  Through his research in esophageal diseases, he is poised to make significant contributions to the field and to our society.”

Leiman earned his medical degree from Vanderbilt and completed both an internal medicine residency and a fellowship in gastroenterology and hepatology at the University of Pennsylvania. He joined the Duke faculty in 2015 and the DCRI in 2017.

Julius Wilder receives Clinical, Translational, and Outcomes Research Award from AASLD

July 11, 2018 -The award is presented to young researchers studying liver disease.

The DCRI’s Julius Wilder, MD, PhD, has received a Clinical, Translational, and Outcomes Research Award from the American Association for the Study of Liver Diseases (AASLD).

The award, which totals $200,000 over two years, is intended to foster career development for individuals performing clinical, translational, or outcomes research in a liver-related area and who have shown commitment to excellence at an early stage of their research study.

Wilder’s award will fund a project to contextualize why poor people, people of color, and people whose native language is not English are at a disadvantage for being listed for liver transplantation. The data generated by Wilder’s study will result in the creation of a intervention project to help patients with end stage liver disease circumnavigate perceived barriers to listing for transplantation.

“Once an individual has end stage liver disease, transplantation is their best option,” Wilder said. “Many lives are lost every year because individuals were unable to gain access to this precious resource. This award will allow me to identify barriers and create solutions for people with end stage liver disease who require a liver transplantation.”

Wilder earned his MD and PhD at Duke and was a DCRI Fellow. He has been a DCRI faculty member since 2016.